Secretory component (SC) is a glycoprotein that mediates the transcellular transport of polymeric immunoglobulins into external secretions. SC is synthesized and inserted into the plasma membrane of epithelial cells and hepatocytes as a transmembrane protein, where it serves as a receptor for polymeric immunoglobulins. SC is posttranslationally cleaved to a soluble protein before secretion into external fluids. In the rat jejunum, we observed that the molecular weights of both the major membrane and soluble forms of SC were 10,000-20,000 smaller than the comparable hepatic forms of the glycoprotein. We therefore set out to determine the reason for the differences in size of SC between these two tissues. The smaller size of jejunal SC was not due to the action of pancreatic proteases or differential glycosylation but was due to proteolysis by a jejunal brush border protease. The protease was characterized as a metalloprotease, with a pH optimum of -5. It is present in jejunal, ileaL and renal tubular brush borders as an integral membrane constituent. When the protease was inhibited in vivo, conversion of jejunal secretory component to the smaller size was partially prevented. Thus, in the rat jejunum, SC undergoes two posttranslational proteolytic events: conversion of membrane secretory component to the soluble form and conversion of soluble SC to a smaller size by a previously undescribed brush border protease.
Introduction
Secretory component (SC)' is a glycoprotein that is synthesized and secreted by epithelial cells in the intestine (1) (2) (3) (4) , mammary gland (5-7), and salivary glands as well as by the hepatocyte of the rat (8, 9) . SC is synthesized as an integral membrane protein (mSC) that is inserted into the abluminal plasma membrane (laterobasal membrane of epithelial cells; sinusoidal membrane of hepatocytes) where it serves as the receptor for polymeric immunoglobulins (pIg). pIg binds to mSC, and the mSC-pIg complex is internalized into a vesicle and transported to the luminal surface of the cell where the complex is secreted (10) (11) (12) . The transcellular transport and secretion of SC also occurs in the absence of pIg; consequently, both soluble SC-pIg complexes (secretory immunoglobulin; slg) and uncomplexed soluble SC (free SC) are present in many external secretions.
sIg and free SC may enter the lumen of the intestine either via the bile or by transport across the enterocyte. While many investigators have examined SC biosynthesis and processing in the hepatocyte (8, 9) or mammary gland (5-7), little is known about the processing of SC in the intestinal cell. We report that in the rat jejunum SC is secreted in a molecular form that is smaller than the SC observed in bile and other glandular secretions. The smaller SC is produced by a proteolytic step mediated by an integral endopeptidase of the jejunal brush border (BB).
Methods
Animals. Male Sprague-Dawley rats (Charles River Breeding Laboratories, Inc., Wilmington, MA) weighing 250-300 g, were used for all experiments. Animals were fasted for 18 h before each experiment. Animals were anesthetized with sodium pentobarbital (50 mg/kg), injected intraperitoneally. Except where noted, all samples of intestinal fluid, bile, and membranes were collected or prepared in the presence of 1 mM phenylmethylsulfonyl fluoride (PMSF) and 50 tg/ml soybean trypsin inhibitor.
Antisera. Monospecific antibody to rat SC was prepared in goats by immunization with SC purified from rat bile as previously described (8) . Rabbit anti-goat IgG conjugated to horseradish peroxidase was purchased from Cooper Biomedical, Inc. (Malvern, PA).
Biological material. Rat liver membranes were prepared by acetone precipitation and 1% sodium dodecyl sulfate (SDS) extraction as previously described (8) . Bile was collected from the proximal common bile duct via a polyethylene cannula (PE10; Clay Adams Div., Becton, Dickinson & Co., Parsippany, NJ) into tubes on ice. The bile was collected either into Laemmli sample buffer (8) containing 1 mM PMSF and 50 ,gg/ml soybean trypsin inhibitor for immediate SDS-polyacrylamide gel electrophoretic (SDS-PAGE) analysis, or into 150 mM NaCl, 1 mM PMSF, 50 ,ug/ml soybean trypsin inhibitor for storage at -20°C and subsequent study.
Jejunal and colonic secretions were collected from isolated loops of gut from 18-h fasted, anesthetized animals. A 25-cm section ofjejunum beginning at the ligament of Treitz, or of the colon from the cecum to rectum, was isolated and cannulated at both ends. The loop was flushed with 150 mM NaCl to remove luminal contents, then perfused with 150 mM NaCl for 1 h to remove adherent biliary-and pancreatic proteases. The loop was perfused for 5 min with 150 mM NaCl containing or lacking protease inhibition (1 mM PMSF, 50 Ag/ml soybean trypsin inhibitor), then clamped at both ends. After 1 h, 2-3 ml of intestinal fluid was aspirated from the loop and centrifuged (13,000 g for 2 min) to remove cells and debris. The supernatant was mixed either with Laemmli sample buffer containing protease inhibitors (1 mM PMSF, 50 ,ug/ ml soybean trypsin inhibitor) for immediate SDS-PAGE analysis or with protease inhibitors (1 mM PMSF, 50 ug/ml soybean trypsin inhibitor) for storage at -20°C. In some experiments, intestinal secretions were collected with additional protection against proteolysis. That is, 150 mM 2-mercaptoethanol (2-ME) was used in place of 150 mM NaCl for perProcessing ofSecretory Component fusion of the loop, and EDTA at a final concentration of 50 mM was added to the secretions.
Jejunal laterobasal membranes (LBM), Golgi membranes, lysosomes, and BB were prepared from mucosal scrapings of jejunal loops. LBM and Golgi membranes were isolated by density gradient ultracentrifugation as previously described (10) . Jejunal, ileal, and renal tubular BB were prepared by Mg++ precipitation (1 1). Lysosomal membranes were prepared by density gradient centrifugation (1 1), using beta glucosaminidase as the marker enzyme. NaK-ATPase, galactosyl transferase, and sucrase activities were used as markers for LBM, Golgi, and BB, respectively (I 1). Enrichment, yield, and recovery ofthe enzyme were calculated as previously described (I 1). In some experiments, jejunal membranes were rapidly prepared in the presence of additional protease inhibitors; isolated jejunal loops were perfused with 150 mM 2-ME, 1 mM PMSF, and 50 ug/ml soybean trypsin inhibitor for 1 h, then flushed with 150 mM 2-ME, and 50 mM EDTA. Mucosal scrapings were homogenized (Polytron homogenizer; Brinkmann Instruments Co., Westbury, NY; setting 6; 30 sec, two times) in 150 mM 2-ME, 50 mM EDTA, 1 mM PMSF, and 50 Mg/ml soybean trypsin inhibitor. The homogenate was centrifuged (750 g for 10 min) to remove cells and nuclei. Membranes were pelleted from the supernate by centrifugation (20,000 g for 20 min), suspended, and boiled (3 min) in Laemmli sample buffer for SDS-PAGE and anti-SC immunoblot analysis.
Rat milk was collected from lactating Sprague-Dawley mothers 3-14 d after delivery. After administration oflight pentobarbital anesthesia and oxytocin (0.03-0.05 cm3/ 100 g body weight), milk was collected by suction with light vacuum directly into an equal volume of 1 mM PMSF and 50 Mg/ml soybean trypsin inhibitor. The whole milk was immediately ultracentrifuged (100,000 g for 30 min), and the whey was drawn off from below the fatty layer. The whey was dialyzed against pH 6 buffer at 4°C for 2 h and recentrifuged (10,000 g for 20 min) to remove the precipitated casein. The supernatant was mixed with an equal amount ofLaemmli sample buffer containing 1 mM PMSF and 50 ,g/ml soybean trypsin inhibitor and stored at 4°C.
Long-term isolatedjejunal loops. In order to collect secretions from jejunal loops that were totally free of pancreatic secretions, long-term isolated loops of jejunum were prepared. Fasted 200-300-g rats were anesthetized, and a 10-1 5-cm section ofjejunum distal to the ligament of Treitz was isolated, leaving the mesenteric vasculature intact. Both ends ofthe isolated loops were brought through incisions in the abdominal wall and anastomosed to the skin. Intestinal continuity was reestablished by a jejuno-jejunostomy. The loops were flushed twice weekly with saline. 4 wk after surgery, secretions from the loops were collected 1 h after filling the loops with 3 ml of 150 mM NaCl, I mM PMSF, and 50 gg/ ml soybean trypsin inhibitor.
Trifluoromethane sulfonic acid (TFMS) deglycosylation. Samples of rat bile, small intestinal secretions, and bovine serum albumin (a nonglycosylated protein) were treated with TFMS, using a modification of a described technique (12) . Bile and jejunal secretions were dialyzed against water to remove salts and then lyophilized. TFMS and anisole were mixed 2:1; and 1 ml of this solution was added to 10-mg samples of lyophilized bile, jejunal secretions, or albumin. After 30 s of dehydration with nitrogen, samples were allowed to react for intervals of 30, 90, and 180 min at 0°C with constant stirring. The reaction was quenched with a 35-fold excess of diethyl ether in 10% n-hexane, and the samples were incubated at -70°C for I h to precipitate proteins. If after 20 min no precipitate was observed, a drop of pyridine was added to cause coprecipitation of sample proteins with the pyridine methane sulfonic salts.
The precipitated proteins were pelleted by centrifugation (1500 g for 10 min), washed twice in ether, and dissolved in 5 ml of H20 by vigorous vortexing. After centrifugation (4000 g for 10 min), the supernatant was dialyzed against H20 and lyophilized. The lyophilized samples were resuspended in Laemmli sample buffer containing protease inhibitors for SDS-PAGE analysis.
In vitro mixing ofbile and BB membranes. 50 ,d of bile was mixed with 50,ug of BB and incubated at 20°C for 30 min. The mixtures were diluted in Laemmli sample buffer and prepared for SDS-PAGE and anti-SC immunoblotting.
After observing that biliary SC was hydrolyzed to a smaller size upon incubation with BB, we partially characterized the SC hydrolytic activity. The pH dependence of the hydrolase was examined by carrying out identical BB-bile incubations over a pH range of 4-10. To determine if the hydrolytic activity was an integral or peripheral protein of the BB, jejunal BB were extracted with 0.5% Triton X-100 or 0.5 M KCI for 1 h at 0°C and centrifuged (13,000 g for 20 min). The supernates and pellets were incubated with bile (20°C for 30 min), and the mixtures were analyzed by SDS-PAGE. To further characterize the hydrolytic activity, RB-bile incubations were conducted in the presence of the following protease inhibitors: 1 mM tosyl-lysine-chloromethylketone; I mM tosylamide-phenyl-ethylchloromethylketone; I mM disiopropylfluorophosphate; 25 ,ug/ml pepstatin; 1 mM p-chloromercuriphenyl sulfonic acid; 1 mM iodoacetamide; 2 mM dithiothreitol (DTT); 100 mM 2 ME; 2 mM EDTA; 40 jg/ml phosphoramidon (only the 2-ME, EDTA, and DTT led to inhibition of the hydrolytic activity). To examine the metal ion dependence of the EDTA inhibition, BB were washed in 50 mM EDTA three times, then washed in 150 mM NaCl three times to remove the EDTA. BB-bile incubations were also carried out in the presence or absence of a variety of divalent metal cations (Ca, Mg, Zn, Mn, Co) at concentrations ranging from 10-3 to 10-6 M.
SDS-PAGE and anti-SC immunoblots. Samples were electrophoretically separated in 8.5% polyacrylamide slab gels using an S-600 apparatus (Hoefer Scientific Instruments, San Francisco, CA) as previously described (8, 13). An aliquot of each sample was stained with Coomassie Blue R250; an identical sample was run on the same gel for immunoblotting of SC. Immunoblots were performed as previously described (8), using goat anti-rat SC followed by horseradish-peroxidase-conjugated rabbit anti-goat IgG. Molecular weight markers (Bio-Rad Laboratories, Richmond, CA) were used on each gel. Since the amount of SC present in the membranes and secretions varied greatly between the organs studied, the amount ofprotein loaded onto each lane ofa given gel was optimized to allow adequate visualization of the immunoreactive SC bands.
Processing ofbiliary SC by the small intestine. In order to characterize the fate of biliary SC in the intestine, bile containing biosynthetically labeled biliary proteins was injected into an isolated loop ofsmall intestine. The bile had been obtained from the proximal bile duct ofanother anesthetized rat after an intraperitoneal injection of I mCi of [3H]fucose (Amersham Corp., Arlington Heights, IL). Aliquots of the radiolabeled bile were then injected into loops ofjejunum that had been isolated in vivo in a separate rat and prepared as described above for collection of jejunal secretions. After a 1-h incubation, the small intestinal contents were collected from the isolated loop, diluted in Laemmli sample buffer, and analyzed by SDS-PAGE and fluorography. To eliminate the effect ofpancreatic proteases on biliary SC, parallel experiments were performed in isolated jejunal loops that had been pretreated by perfusion with 150 mM NaCl, containing 1 mM PMSF and 50 Ag/ml soybean trypsin inhibitor for 1 h before injection of radiolabeled bile. To differentiate between the effects ofjejunal secretions and brush border constituents on biiary SC, aliquots of radiolabeled bile were incubated with jejunal secretions or saline for 1 h at 37°C in the presence or absence of 1 mM PMSF and 50 Mg/ml soybean trypsin inhibitor.
Results
Molecularforms ofSC. The molecular forms ofSC in bile, milk, jejunal secretions, and colonic secretions were identified by immunoblots. Bile, milk, and colonic secretions contained an SC doublet (82,000 and 78,000 molecular weight [mol wt]), whereas jejunal secretions contained a smaller form of SC that was predominantly a single 70,000-mol-wt band (Fig. 1 in the jejunum, was 10,000-20,000 mol wt smaller than SC prepared in a similar manner from the liver (Fig. 2) .
When secretions were collected from loops ofjejunum that had been isolated from pancreatic secretions for 4 wk, a single 70,000-mol-wt form of SC was present (Fig. 3) . This SC was identical in size to that present in jejunal secretions collected from intact jejunal loops and smaller than biliary SC. Thus, the smaller size ofjejunal SC was not due to the action of pancreatic proteases.
TFMS deglycosylation. In order to determine if jejunal SC was smaller than biliary SC because of differential glycosylation, bile and jejunal secretions were subjected to TFMS-mediated deglycosylation and immunoblotting for SC (Fig. 4) . Although originally reported to remove 0-linked sugars, TFMS deglycosylation of N-linked carbohydrates has been subsequently dem- Figure 3 . Molecular forms of SC in secretions from long-term isolated jejunal loops. Intestinal secretions were collected from loops ofjejunum that had been isolated from pancreatic secretions in vivo for 4 wk (see text for surgical details), and were subjected to SDS-PAGE and anti-SC immunoblots. Secretions from the long-term isolated jejunal loops contained SC that was identical in size to that found in intestinal secretions from an intact jejunal loop (intestinal secretions) and about 10,000 mol wt smaller than the SC doublet found in bile.
onstrated (14) . After 30 min of incubation with TFMS, SC in both the bile and jejunal secretions was decreased by about 7,000 mol wt. Similarly, after 90 and 180 min, SC from both secretions MEMBRANE FORMS of pancreatic protease inhibitors (1 mM PMSF and 50 ,g/ml soybean trypsin inhibitor) and subjected to SDS-PAGE and anti-SC immunoblots. In the small intestine, both the membrane (laterobasal mem) and secreted (intestinal sec) forms of SC were single bands that were about 10,000-20,000 mol wt smaller than the doublets present in comparable preparations from the liver (liver membrane and bile). Processing ofbiliary SC by the small intestine. To determine if the smaller size of the jejunal forms of SC was the result of the action of a constituent of jejunal secretions or the jejunal brush border, the fate of biliary SC in the small intestine was examined. Bile collected after an intraperitoneal injection of [3HJfucose contained four major fucoproteins, including SC (Fig.  5) ; in bile reduced with 2-ME, SC was the largest demonstrable fucopeptide. After incubation of radiolabeled bile in vivo in the isolated loop the amount of radioactivity that could be loaded on the gel was limited because of dilution with jejunal secretions. Nonetheless, in the presence of the protease inhibitors, the 82,000-and 78,000-mol-wt doublet of biliary SC were greatly reduced and a 70,000-mol-wt radiolabeled band appeared. None ofthe other radiolabeled biliary proteins were altered significantly in size during the incubation. Since the only band larger than 70,000 mol wt present in the reduced bile was SC, it appeared 3H -B I LE Pius Saline P I + Si sec that biliary SC was degraded to a 70,000-mol-wt form in the jejunal loop. Incubation of radiolabeled bile with jejunal secretions or with NaCl did not modify the biliary profile or result in the appearance ofthe 70,000-mol-wt band (Fig. 5) . Thus, the jejunal surface, but not the jejunal secretions, was capable of converting the biliary form of SC into a form that was similar to that observed in jejunal secretions. This processing appeared to be specific for SC since none of the other biliary proteins appeared to be degraded.
BB-bile mixing experiments. In order to test the possibility that jejunal BB were capable of proteolytically processing SC, biliary SC was incubated with purified jejunal BB membranes (20-fold enriched for sucrase activity with 15% yield). No SC was identified in the purified BB preparation (Fig. 6) . After incubation with BB, the anti-SC immunoblot demonstrated that the biliary SC doublet was partially converted to a 70,000-molwt immunoreactive form. This conversion product could be seen also in the Coomassie-stained gel by the appearance ofa 70,000-mol-wt protein band in the BB-bile mixture (Fig. 6) Partial characterization ofBB hydrolase. Fig. 7 shows that the hydrolysis ofbiliary SC to the 70,000-mol-wt form by jejunal BB had a pH optimum of -5. Less efficient hydrolysis (25-45%) occurred, however, over a pH range from 6 to 9. The hydrolytic activity was not present in the 0.5 M KC1 extract but was present in the 0.5% Triton extract ofjejunal BB (Fig. 8) .
The hydrolytic activity was not inhibited by the serine protease inhibitors, PMSF, soybean trypsin inhibitor, tosylamidephenyl-ethylchloromethylketone, tosyl-lysine-chloromethylketone, or diisopropylfluorophosphate; nor was it inhibited by the carboxyl protease inhibitor, pepstatin, or the thiol protease inhibitors, p-chloromercuriphenyl sulfonic acid or iodoacetamide. However, it was inhibited by the metalloprotease inhibitors 2-ME, DTT, and EDTA. No inhibition, however, was observed with the neutral endopeptidase (a BB metalloprotease) inhibitor phosphoramidon. The EDTA-mediated inhibition of the hydrolase (Fig. 9 ) was partially reversed with the addition of 10-6 M Zn (10-4 M Zn was required for complete reversal of the EDTA-mediated inhibition), whereas Ca or Mg was required at a IO-' M concentration before any reversal of inhibition was observed; Co and Mn failed to reverse the inhibition at any concentration tested (l03-l0-6 M).
Jejunal membranes and secretions prepared with metalloprotease protection. Jejunal membranes prepared in the presence ofmetalloprotease inhibitors (150 mM 2-Me and 50 mM EDTA) contained an SC doublet that was of a size comparable to that found in liver membranes (Fig. 10, Membranes) . Similarly, jejunal secretions collected in the presence of metalloprotease inhibitors contained an SC form similar in size to biliary SC and was 10,000-15,000 mol wt larger than SC in jejunal secretions collected without metalloprotease inhibitors (Fig. 10, Secretions) . It should be noted that collection ofjejunal secretions with the high concentration of 2-ME was difficult. In some experiments it resulted in dissociation of substantial numbers of enterocytes into the lumen and it consistently distorted the SDS-PAGE and immunoblot profile, as can be seen in Fig. 10 (Secretions).
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-I Figure 7 . pH dependence of proteolytic conversion of biliary SC by jejunal BB. Incubations of bile and BB were carried out as in Fig. 6 , except that the pH of the mixture was varied. Aliquots of incubations at each pH were analyzed by anti-SC immunoblots. The percent conversion of biliary SC to the 70,000-mol-wt form was calculated by laser densitometry of the immunoblots. The anti-SC immunoblot in the box shows the SC bands in the incubation mixtures at each pH in comparison to biliary SC (closed arrow).
Discussion
The results of this study demonstrate that in the jejunum, SC undergoes two sequential posttranslational processing steps. The first step is the conversion of membrane SC to soluble SC by the cleavage of a 20,000-mol-wt membrane-anchoring domain.
The second step results in conversion of the bulk of soluble SC from an 80,000-to a 70,000-mol-wt form. These two steps do not appear to be mediated by the same enzyme since inhibition of the BB hydrolase responsible for the second proteolytic step Figure 9 . Metal ion dependence ofjejunal BB hydrolase. Nontreated (-); EDTA-washed (EDTA); or EDTA-treated, zinc repleted (EDTA + Zn) BB were incubated with bile as in Fig. 6 . Aliquots of the BB, bile, and each mixture were analyzed by SDS-PAGE and Coomassie did not halt secretion of SC into jejunal secretions. Our observation of the assessed molecular weight of membrane SC in the rat liver (1 10,000 and 100,000) are different than those reported by Sztul et al. (120,000 and 105,000 [15, 16] ). This apparent discrepancy is due to a difference in the electrophoretic conditions. Under reducing conditions (as used by Sztul et al.), our liver membrane SC has an apparent molecular weight of 115,000 and 105,000. Solubilization of mSC by proteolytic cleavage ofa membrane anchoring domain has been demonstrated in rabbit mammary gland (6, 7), a human colonic cell line (4), and rat liver (8, 15, 16 ). Our results not onty suggest that a similar proteolytic solubilization step occurs in the rat jejunum but that they also provide additional information about the solubilization step. The finding of a similar 20,000-mol-wt size difference between mSC and secreted SC in both the small intestine and the liver suggests that a similar (or identical) protease is responsible for SC solubilization in both tissues. The observation that mSC was present in jejunal LBM but not in BB suggests that cleavage of the anchoring peptide occurs either in the transport vesicle or rapidly enough after fusion of the transport vesicle with the BB MEMBRANES" to prevent membrane SC from accumulating in the BB. Our observations are in agreement with electron microscopic evidence from our laboratory that localized SC on the LBM but not on the BB of rat jejunum (3). The finding of Solari and Kraehenbuhl (7) that the membrane anchoring domain of SC is present in the luminal membrane ofmammary gland epithelial cells suggests that if the cleavage occurs in the transport vesicle both portions of the cleaved molecule reach the luminal membrane. In the rat liver, both immunoelectron microscopic (17) and cell fractionation data (15, 16, 18) suggest that solubilization occurs, at least in part, on the canalicular membrane. The precise site of cleavage of membrane to soluble SC in the intestine is currently under investigation in our laboratory.
In contrast to the similarities in the processing of mSC in the liver and the jejunum, we observed one distinct difference in SC processing by these organs. This difference was suspected when we observed that the major form ofSC in jejunal secretions and membranes was a different molecular form (both smaller and a single band rather than a doublet) from that in the other organs studied. Several possible explanations for the smaller size of SC in the jejunum were considered. First, since activated Renal tubular cell microvillar membranes, however, do contain the protease. Thus, the SC-endopeptidase distribution is similar to that of several other intestinal microvillar membrane peptidases, such as the aminopeptidases (20) .
The purpose of the hydrolysis of SC to the 70,000-mol-wt form in the small intestine is not clear. It is not essential for secretion of SC because inhibition of the proteolytic step with 2-ME does not prevent SC secretion in the jejunum and SC secretion proceeds in the colon in the absence ofthe proteolytic step. In the small intestine, the step does not appear to be obligatory in that a small portion of SC in jejunal secretions remains uncleaved ( Fig. 1 ) and a small portion of biliary SC is not converted to the 70,000-mol-wt size in the isolated intestinal loop (Fig. 5 ). Both free SC and SC complexed with IgA appear to undergo this processing step since the 70,000-mol-wt form of SC is also the major form found in gels of reduced fluids containing slg (conditions that would dissociate covalently bound SC from IgA). The processing step likely occurs at the time of, or after, secretion of SC into the lumen since the protease is located strictly in the BB. Consequently, the processing step is unlikely to have a role in the binding ofpIg to SC, which occurs on the abluminal face ofthe cell, or in the transcellular transport of pIg. The BB hydrolytic activity is quite specific for SC; of all the proteins present in the bile, only SC appeared to be degraded after mixing with BB membranes. Whether this hydrolysis of SC by the jejunal BB protease results in any alteration in SC function remains to be determined. The finding of a doublet of SC in rat liver membranes and bile is consistent with previous observations from our (8) and other laboratories (9, 16) . Sztul et al. (16) observed three molecular forms of SC: an intracellular 105,000-mol-wt precursor that was converted to a 116,000-mol-wt form in the Golgi and subsequently converted to a 120,000-mol-wt form at the plasma membrane. The explanation for the presence of two soluble SC bands is not yet established; carbohydrate heterogeneity or proteolysis seem the most likely explanations. Both genetic and carbohydrate heterogeneity have been reported to account for the multiple molecular forms of SC found in the rabbit (5, 6, 23) . The observation that the biliary doublet is converted by the BB hydrolase to a single 70,000-mol-wt immunoreactive band suggests that if carbohydrate heterogeneity accounts for the SC doublet, the region containing the carbohydrate differences is removed by the BB protease.
In summary, we have demonstrated that in the rat jejunum SC undergoes two posttranslational processing steps. The first step is the conversion of membrane SC to soluble SC by cleavage ofthe membrane-anchoring domain. This solubilization occurs by a mechanism similar to that for solubilization of SC in the liver and other glandular organs. The second step occurs only in the jejunum and results in cleavage of an additional 10,000-mol-wt portion from SC. The second posttranslational processing step is mediated by a specific protease present in jejunal brush border membranes. SC is the only endogenous substrate idenProcessing ofSecretory Component 1847 tified for the protease. The SC-endopeptidase is an integral BB metalloprotease with an acidic pH optimum and appears to be distinct from any previously described jejunal BB protease.
